Cite
Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial.
MLA
Ko, Jenny J., et al. “Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial.” Current Oncology (Toronto, Ont.), vol. 30, no. 4, Mar. 2023, pp. 3817–28. EBSCOhost, https://doi.org/10.3390/curroncol30040289.
APA
Ko, J. J., Banerji, S., Blais, N., Brade, A., Clelland, C., Schellenberg, D., Snow, S., Wheatley-Price, P., Yuan, R., & Melosky, B. (2023). Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial. Current Oncology (Toronto, Ont.), 30(4), 3817–3828. https://doi.org/10.3390/curroncol30040289
Chicago
Ko, Jenny J, Shantanu Banerji, Normand Blais, Anthony Brade, Cathy Clelland, Devin Schellenberg, Stephanie Snow, Paul Wheatley-Price, Ren Yuan, and Barbara Melosky. 2023. “Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial.” Current Oncology (Toronto, Ont.) 30 (4): 3817–28. doi:10.3390/curroncol30040289.